Brief: Aldeyra Therapeutics Announces Expansion of RASP Platform
13/11/2025 12:29
Nov 13 (Reuters) - Aldeyra Therapeutics Inc ALDX.O: ALDEYRA THERAPEUTICS ANNOUNCES EXPANSION OF RASP PLATFORM TO INCLUDE CENTRAL NERVOUS SYSTEM DISEASES AND PROVIDES UPDATES ON REPROXALAP AT RESEARCH & DEVELOPMENT WEBCAST Source text: ID:nBw3zyHBba Further company coverage: ALDX.O ((reuters.briefs@thomsonreuters.com;))
Recent news on Aldeyra Therapeutics
See all newsBrief: Aldeyra Therapeutics Pays Off $15 Million Outstanding Borrowings, Terminates Hercules Credit Facility - SEC Filing
U.S. STOCKS ON THE MOVE -Steel Dynamics, Aldeyra, Cencora
U.S. STOCKS ON THE MOVE-Qualcomm, Canadian Solar, Draftkings
Aldeyra tumbles to record low after FDA declines to approve experimental dry eye drug
Aldeyra plunges after FDA declines to approve experimental dry eye drug